Maxcyte (MXCT) Common Equity (2020 - 2026)
Maxcyte (MXCT) posted quarterly Common Equity of $167.9 million for Q1 2026, down 15.81% year-over-year from $199.4 million in Q1 2025, and down 2.1% quarter-over-quarter from $171.5 million in Q4 2025.
Maxcyte (MXCT) Common Equity (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Common Equity for 7 consecutive years, with $167.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 15.81% year-over-year to $167.9 million; the TTM figure through Mar 2026 stood at $167.9 million (down 15.81% YoY), while the FY2025 annual figure was $171.5 million, down 16.85% from the prior year.
- Common Equity declined to $167.9 million in Q1 2026 per MXCT's latest filing, from $171.5 million in the prior quarter.
- Across five years, Common Equity topped out at $262.2 million in Q1 2022 and bottomed at $167.9 million in Q1 2026.
- Historically, Common Equity has averaged $221.1 million across 5 years, with a median of $226.4 million in 2024.
- Annual changes were most pronounced in 2022 — Common Equity jumped 226.34% — and 2025, when it slipped 16.85%.
- Maxcyte's Common Equity stood at $254.0 million in 2022, then declined by 8.58% to $232.2 million in 2023, then retreated by 11.16% to $206.3 million in 2024, then retreated by 16.85% to $171.5 million in 2025, then decreased by 2.1% to $167.9 million in 2026.
- Business Quant data shows MXCT's Common Equity at $167.9 million in Q1 2026, $171.5 million in Q4 2025, and $180.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | 158.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158.75 Mn |
| Mar 31, 2026 | 167.89 Mn |
| Dec 31, 2025 | 171.49 Mn |
| Sep 30, 2025 | 180.28 Mn |
| Jun 30, 2025 | 190.72 Mn |
| Mar 31, 2025 | 199.41 Mn |
| Dec 31, 2024 | 206.25 Mn |
| Sep 30, 2024 | 213.30 Mn |
| Jun 30, 2024 | 221.26 Mn |
| Mar 31, 2024 | 226.36 Mn |
| Dec 31, 2023 | 232.17 Mn |
| Sep 30, 2023 | 233.38 Mn |
| Jun 30, 2023 | 240.98 Mn |
| Mar 31, 2023 | 247.82 Mn |
| Dec 31, 2022 | 253.97 Mn |
| Sep 30, 2022 | 254.43 Mn |
| Jun 30, 2022 | 257.22 Mn |
| Mar 31, 2022 | 262.18 Mn |
| Dec 31, 2021 | 262.90 Mn |
| Sep 30, 2021 | 264.12 Mn |